Casting a wider net for countermeasure r&d funding decisions.

Casting a wider net for countermeasure r&d funding decisions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Casting a wider net for countermeasure r&d funding decisions. Abstract Text:

Lynn Klotz,Lynn Klotz,

Among potential bioweapons attacks, endemic infectious diseases (that is, those naturally occurring diseases that afflict us every year), and a potential influenza pandemic, how should we apportion funding and resources for basic research and countermeasure development? To address this question, I argue for a "combined risk assessment" that considers bioweapons attacks with natural pandemics and endemic infectious disease. At present, risk assessments for bioweapons attacks are carried out separately from the assessments long carried out for endemic infectious diseases to make public health and medical care decisions. One result of this separation is that funding decisions may be unduly influenced by an overblown fear of a big bioweapons attack and by political whim. The result of the simplified combined risk assessment presented here argues for more funding and resources for endemic infectious disease and for placing biodefense against anthrax and other bioweapons in a place lower in the risk hierarchy. Since the assessment here considers only fatalities to make the point that our priorities are skewed, the conclusions are only a "first word" on the subject, far from the last. Furthermore, the impact of other issues on priorities, such as national and international policy, is not considered. It is a call for a debate on the public stage of the policy and other rationale and the quantitative risk assessment arguments that now place bioweapons attacks at the top of our risk ranking.

Casting a wider net for countermeasure r&d funding decisions. Publishing Authors By Initials

L Klotz,L Klotz,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Casting a wider net for countermeasure r&d funding decisions. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biosecurity and bioterrorism : biodefense strategy

VOLUME: 5

Page Numbers: 313-8

Journal Abbreviation:

ISSN: 1538-7135

DAY: 17

MONTH: Dec

YEAR: 2007

Casting a wider net for countermeasure r&d funding decisions. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101156085

Casting a wider net for countermeasure r&d funding decisions. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Casting a wider net for countermeasure r&d funding decisions. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Casting a wider net for countermeasure r&d funding decisions.

AFFILIATION: 5 Duley Street, Gloucester, MA 01930. Lynnklotz@cs.com.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biosecur Bioterror

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Casting a wider net for countermeasure r&d funding decisions Related Publications

• Active surveillance for favorable risk prostate cancer: Rationale, risks, and results.
• Active surveillance for favorable risk prostate cancer: what are the results, and how safe is it?
• Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?
• An Sfi1p-Like Centrin-Binding Protein Mediates Centrin-Based Ca2+-Dependent Contractility in Paramecium tetraurelia.
• Antiarrhythmics : elimination and dosage considerations in hepatic impairment.
• Casting a wider net for countermeasure r&d funding decisions.
• Characterization of Two New Genes, amoR and amoD, in the amo Operon of the Marine Ammonia Oxidizer Nitrosococcus oceani ATCC 19707.
• Drug-related risks.
• Epidermal growth factor- and stress-induced loss of gap junctional communication is mediated by ERK-1/ERK-2 but not ERK-5 in rat liver epithelial cells.
• How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?
• Nomadic or sessile: can Kupffer cells function as portals for malaria sporozoites to the liver?
• North American blastomycosis (Gilchrist's disease) a study of the disease from a review of the literature.
• North American blastomycosis (Gilchrist's disease) an analysis of Canadian reports and description of a new case of the systemic type.
• Pencil penetrates orbit.
• Some aspects of the action of sulfonamides; rate-controlling processes in growth studies with Escherichia coli.
• Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor.
• The bridging function of clinical pharmacology.
• The impact of genome analyses on our understanding of ammonia-oxidizing bacteria.
• Thorn in body causing abscess after 21 years.
• Transport studies with 5-aminosalicylate.
• Unchanged serum levels of advanced glycation endproducts in patients with liver disease.
• [Healthy lifestyles and help-seeking in males - no improvement in sight.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]